AFA
ABBV icon

American Financial Advisors’s AbbVie ABBV Stock Holding History

American Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
1,492
+7
+0.5% +$1.51K 0.05% 114
2026
Q1 		$323K Sell
1,485
-163
-10% -$36.2K 0.04% 116
2025
Q4 		$377K Buy
1,648
+11
+0.7% +$2.51K 0.05% 109
2025
Q3 		$379K Buy
1,637
+31
+2% +$6.31K 0.05% 110
2025
Q2 		$298K Buy
1,606
+15
+0.9% +$2.79K 0.04% 122
2025
Q1 		$333K Sell
1,591
-340
-18% -$66.1K 0.05% 105
2024
Q4 		$343K Sell
1,931
-309
-14% -$56.8K 0.05% 101
2024
Q3 		$442K Sell
2,240
-95
-4% -$17.7K 0.06% 88
2024
Q2 		$401K Sell
2,335
-267
-10% -$44.2K 0.06% 92
2024
Q1 		$474K Buy
2,602
+21
+0.8% +$3.62K 0.07% 87
2023
Q4 		$400K Buy
2,581
+25
+1% +$3.65K 0.06% 90
2023
Q3 		$381K Buy
2,556
+21
+0.8% +$3.08K 0.06% 91
2023
Q2 		$342K Sell
2,535
-269
-10% -$39.4K 0.05% 94
2023
Q1 		$447K Buy
2,804
+21
+0.8% +$3.21K 0.07% 89
2022
Q4 		$450K Buy
2,783
+18
+0.7% +$2.76K 0.08% 83
2022
Q3 		$371K Buy
+2,765
New +$397K 0.06% 88
2022
Q2 		– Sell
-2,788
Closed -$452K – 75
2022
Q1 		$452K Sell
2,788
-347
-11% -$50.4K 0.06% 87
2021
Q4 		$424K Sell
3,135
-26
-0.8% -$3.07K 0.05% 92
2021
Q3 		$341K Buy
3,161
+172
+6% +$19.7K 0.05% 100
2021
Q2 		$337K Buy
2,989
+23
+0.8% +$2.59K 0.05% 99
2021
Q1 		$321K Buy
2,966
+73
+3% +$7.81K 0.05% 98
2020
Q4 		$310K Buy
+2,893
New +$278K 0.04% 95
2020
Q3 		– Sell
-2,136
Closed -$207K – 110
2020
Q2 		$207K Buy
+2,136
New +$188K 0.03% 101

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

American Financial Advisors's ABBV Position: Q2 2026 in Review

American Financial Advisors increased its AbbVie (ABBV) stake by 0.47% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,492 shares worth $376K. The position accounts for 0.05% of the portfolio, ranked #114.

American Financial Advisors first reported a position in ABBV in Q2 2020 and has held it in 23 quarters since. The position peaked at $474K in Q1 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • American Financial Advisors held 1,492 shares of AbbVie worth $376K as of Q2 2026.
  • American Financial Advisors bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.05% of American Financial Advisors's portfolio in Q2 2026, its #114 holding.
  • American Financial Advisors first reported a position in AbbVie in Q2 2020 and has held it in 23 quarters since.
  • American Financial Advisors's AbbVie position peaked at $474K in Q1 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on American Financial Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.